3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
28
Lung Neoplasms
27
Neoplasm Metastasis
26
Carcinoma, Non-Small-Cell Lung
21
Multiple Myeloma
18
Urinary Bladder Neoplasms
16
Breast Neoplasms
16
Lymphoma
15
Glioma
14
Colorectal Neoplasms
14
Pancreatic Neoplasms
13
Lymphoma, Large B-Cell, Diffuse
13
Carcinoma, Renal Cell
13
Squamous Cell Carcinoma of Head and Neck
12
Ovarian Neoplasms
12
Melanoma
12
Triple Negative Breast Neoplasms
11
Glioblastoma
10
Oropharyngeal Neoplasms
9
Mouth Neoplasms
9
Fallopian Tube Neoplasms
9
Carcinoma
9
Sarcoma
8
Lymphoma, Non-Hodgkin
8
Endometrial Neoplasms
8
Carcinoma, Transitional Cell
8
Medulloblastoma
7
Lymphoma, Follicular
7
Laryngeal Neoplasms
7
Carcinoma, Hepatocellular
7
Interventions
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastro-enteropancreatic neuroendocrine tumor
×
Magnetic Resonance Spectroscopy
×
30 days
×
Clear all
No trials found.